$4.61
0.040.99%
Pre-Market: 5:44 PM EDT
15 minutes delayed
Annexon: Insider buying and selling updated today.
Jul 02, 2024 | William Carson | — | 3.2K | $5.00 | $16.00K | BUY | 33.33% | 12.8K | Jul 01 | View |
Jun 05, 2024 | William Carson | — | 3.2K | $4.83 | $15.46K | BUY | 50.00% | 9.6K | Jun 03 | View |
May 03, 2024 | William Carson | — | 3.2K | $4.68 | $14.98K | BUY | 100.00% | 6.4K | May 01 | View |
Apr 10, 2024 | William Carson | — | 3.2K | $6.07 | $19.41K | BUY | ∞ | 3.2K | Apr 08 | View |
Feb 21, 2024 | Jennifer Lew | EVP & CHIEF FINANCIAL OFFICER | 36.407K | $5.53 | -$14.34K | GRANT | 79.75% | 82.058K | Feb 16 - Feb 20 | View |
Feb 21, 2024 | Ted Yednock | EVP & CHIEF INNOVATION OFFICER | 36.396K | $5.51 | -$14.35K | GRANT | 63.77% | 93.471K | Feb 16 - Feb 20 | View |
Feb 21, 2024 | Michael Overdorf | EVP & CHIEF BUSINESS OFFICER | 37.049K | $5.48 | -$10.69K | GRANT | 76.25% | 85.641K | Feb 16 - Feb 20 | View |
Feb 14, 2024 | Michael Overdorf | EVP & CHIEF BUSINESS OFFICER | -1.349K | $5.53 | -$7.46K | SELL | -2.70% | 48.592K | Feb 12 | View |
Feb 14, 2024 | Douglas Love | PRESIDENT AND CEO | -5.782K | $5.54 | -$32.03K | SELL | -2.86% | 196.121K | Feb 12 | View |
Feb 14, 2024 | Jennifer Lew | EVP & CHIEF FINANCIAL OFFICER | -1.809K | $5.54 | -$10.02K | SELL | -3.81% | 45.651K | Feb 12 | View |
Feb 14, 2024 | Ted Yednock | EVP & CHIEF INNOVATION OFFICER | -1.81K | $5.54 | -$10.03K | SELL | -3.07% | 57.075K | Feb 12 | View |
Jan 23, 2024 | Michael Overdorf | EVP & CHIEF BUSINESS OFFICER | -978 | $3.84 | -$3.75K | SELL | -2.09% | 45.802K | Jul 11 | View |
Jan 23, 2024 | Jennifer Lew | EVP & CHIEF FINANCIAL OFFICER | -1.057K | $3.84 | -$4.05K | SELL | -2.18% | 47.46K | Jul 11 | View |
Dec 29, 2023 | Ted Yednock | EVP & CHIEF INNOVATION OFFICER | 0 | $3.07 | -$60.79K | SELL-OPTIONS | 0.00% | 0 | Dec 27 | View |
Dec 28, 2023 | Muneer A Satter | DIRECTOR | 350K | $2.88 | $1.01M | BUY | 4.96% | 7.406024M | Dec 26 | View |
May 30, 2023 | Bain Capital Life Sciences Investors LLCBain Capital Life Sciences Fund LPBain Capital Life Sciences Partners LPBCIP Life Sciences Associates LP | 10% OWNER | 300K | $2.13 | $639.72K | BUY | 5.55% | 5.701926M | May 25 | View |
Feb 17, 2023 | Douglas Love | PRESIDENT & CEO | -6.571K | $5.87 | -$38.56K | SELL | -3.22% | 197.646K | Feb 15 | View |
Feb 15, 2023 | Michael Overdorf | EVP & CHIEF BUSINESS OFFICER | -1.645K | $6.30 | -$10.37K | SELL | -5.59% | 27.805K | Feb 13 - Feb 14 | View |
Feb 15, 2023 | Jennifer Lew | EVP & CHIEF FINANCIAL OFFICER | -1.908K | $6.31 | -$12.04K | SELL | -6.07% | 29.542K | Feb 13 - Feb 14 | View |
Feb 14, 2023 | Muneer A Satter | DIRECTOR | 2.647058M | $6.80 | $18.00M | BUY | 60.04% | 7.056024M | Feb 10 | View |
Jul 11, 2022 | Muneer A Satter | DIRECTOR | 2.453988M | $3.84 | $9.42M | BUY | 125.53% | 4.408966M | Jul 07 | View |
Apr 18, 2022 | Douglas Love | PRESIDENT & CEO | 60K | $2.45 | $146.81K | BUY | 42.57% | 200.942K | Apr 14 | View |
Sep 20, 2021 | Douglas Love | PRESIDENT & CEO | 0 | $11.73 | -$154.77K | SELL-OPTIONS | 0.00% | 0 | Sep 16 | View |
Sep 15, 2021 | Ted Yednock | EVP & CHIEF SCIENTIFIC OFFICER | 0 | $10.84 | -$296.64K | SELL-OPTIONS | 0.00% | 0 | Sep 13 | View |
Sep 15, 2021 | Jennifer Lew | EVP & CHIEF FINANCIAL OFFICER | 0 | $13.75 | -$43.82K | SELL-OPTIONS | 0.00% | 2K | Sep 13 | View |
Jun 09, 2021 | Douglas Love | PRESIDENT & CEO | 0 | $11.92 | -$157.66K | SELL-OPTIONS | 0.00% | 0 | Jun 07 - Jun 08 | View |
Jun 07, 2021 | Ted Yednock | EVP & CHIEF SCIENTIFIC OFFICER | 0 | $11.45 | -$301.18K | SELL-OPTIONS | 0.00% | 0 | Jun 03 | View |
Jun 01, 2021 | Jennifer Lew | EVP & CHIEF FINANCIAL OFFICER | 0 | $14.86 | -$51.63K | SELL-OPTIONS | 0.00% | 2K | May 27 | View |
Apr 02, 2021 | Douglas Love | PRESIDENT & CEO | 0 | $14.76 | -$202.95K | SELL-OPTIONS | 0.00% | 0 | Mar 31 - Apr 01 | View |
Mar 31, 2021 | Douglas Love | PRESIDENT & CEO | 0 | $13.19 | -$176.73K | SELL-OPTIONS | 0.00% | 0 | Mar 29 - Mar 30 | View |
Mar 29, 2021 | Ted Yednock | EVP & CHIEF SCIENTIFIC OFFICER | 0 | $15.24 | -$438.62K | SELL-OPTIONS | 0.00% | 0 | Mar 25 | View |
Mar 26, 2021 | Sanjay Keswani | EVP & CHIEF MEDICAL OFFICER | 0 | $18.83 | -$90.60K | SELL-OPTIONS | 0.00% | 0 | Mar 24 | View |
Mar 25, 2021 | Jennifer Lew | EVP & CHIEF FINANCIAL OFFICER | 0 | $17.96 | -$104.73K | SELL-OPTIONS | 0.00% | 2K | Mar 23 | View |
Jul 30, 2020 | Clarus Lifesciences III LPClarus Ventures III GP LPBlackstone Clarus III LLCBlackstone Holdings II LPBlackstone Holdings III GP LLCBlackstone Group IncBlackstone Group Management LLCSTEPHEN SCHWARZMAN | — | 2.730635M | $17.00 | $3.40M | DERIVATIVE CONVERSION | ∞ | 2.730635M | Jul 28 | View |
Jul 28, 2020 | Bain Capital Life Sciences Investors LLCBain Capital Life Sciences Fund LPBCIP Life Sciences Associates LPAdam KoppelBain Capital Life Sciences Partners LPLawrence Jeffrey Schwartz | — | 3.241628M | $17.00 | $6.80M | DERIVATIVE CONVERSION | ∞ | 3.241628M | Jul 28 | View |
Jul 28, 2020 | Jennifer Lew | — | 2K | $17.00 | $34.00K | PURCHASE | ∞ | 2K | Jul 28 | View |
Jul 28, 2020 | Muneer A Satter | — | 1.954978M | $17.00 | $3.40M | DERIVATIVE CONVERSION | ∞ | 1.954978M | Jul 28 | View |
Jul 28, 2020 | James FlynnDeerfield Mgmt IV LPDEERFIELD MANAGEMENT COMPANY LP SERIES CDeerfield Private Design Fund IV LPDeerfield Mgmt LPDEERFIELD PARTNERS LP | — | 1.617828M | $17.00 | $11.90M | DERIVATIVE CONVERSION | ∞ | 808.914K | Jul 28 | View |
Browse insider trades on all stocks.